Maryland Resident Population Per Square Mile: 2010-2020

Resident population density for Maryland and Jurisdictions per square mile from 2010 to 2020. Source: U.S. Bureau of Census

Dispensation Data without Buprenorphine Quarter 3 2016 - Current Quarterly County Health

View quarterly trends in opioid dispensation data for all Schedule II-V opioids. Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx More information from U.S. Department of Justice https://www.deadiversion.usdoj.gov/schedules/ Schedule I Controlled Substances Substances in this schedule have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse. Some examples of substances listed in Schedule I are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), peyote, methaqualone, and 3,4-methylenedioxymethamphetamine ("Ecstasy"). Schedule II/IIN Controlled Substances (2/2N) Substances in this schedule have a high potential for abuse which may lead to severe psychological or physical dependence. Examples of Schedule II narcotics include: hydromorphone (Dilaudid®), methadone (Dolophine®), meperidine (Demerol®), oxycodone (OxyContin®, Percocet®), and fentanyl (Sublimaze®, Duragesic®). Other Schedule II narcotics include: morphine, opium, codeine, and hydrocodone. Examples of Schedule IIN stimulants include: amphetamine (Dexedrine®, Adderall®), methamphetamine (Desoxyn®), and methylphenidate (Ritalin®). Other Schedule II substances include: amobarbital, glutethimide, and pentobarbital. Schedule III/IIIN Controlled Substances (3/3N) Substances in this schedule have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence. Examples of Schedule III narcotics include: products containing not more than 90 milligrams of codeine per dosage unit (Tylenol with Codeine®), and buprenorphine (Suboxone®). Examples of Schedule IIIN non-narcotics include: benzphetamine (Didrex®), phendimetrazine, ketamine, and anabolic steroids such as Depo®-Testosterone. Schedule IV Controlled Substances Substances in this schedule have a low potential for abuse relative to substances in Schedule III. Examples of Schedule IV substances include: alprazolam (Xanax®), carisoprodol (Soma®), clonazepam (Klonopin®), clorazepate (Tranxene®), diazepam (Valium®), lorazepam (Ativan®), midazolam (Versed®), temazepam (Restoril®), and triazolam (Halcion®). Schedule V Controlled Substances Substances in this schedule have a low potential for abuse relative to substances listed in Schedule IV and consist primarily of preparations containing limited quantities of certain narcotics. Examples of Schedule V substances include: cough preparations containing not more than 200 milligrams of codeine per 100 milliliters or per 100 grams (Robitussin AC®, Phenergan with Codeine®), and ezogabine.

Pennsylvania Professional Licensee Data County State

This dataset contains counts of professional licensees per each licensed occupation and is broken down by County of licensee. *Appearances of non-Pennsylvania counties in the data are due to practitioners that are either licensed to practice in Pennsylvania but live out of state or own a facility in Pennsylvania but live out of state. **Appearances of null values in the data are due to the county field being an optional field for a license application and the county does not auto populate based on the address at this point in time.

Buprenorphine Dispensation Data Quarter 3 2016 - Current Quarterly Statewide Health

View quarterly trends in buprenorphine dispensation data. Please note that buprenorphine data received by the PDMP is restricted to prescriptions filled by pharmacies. The PDMP does not collect information on the reason a controlled substance is prescribed, nor does it collect data from substance abuse treatment facilities or dispensing prescribers providing buprenorphine for substance abuse treatment. Buprenorphine is sometimes prescribed off-label for pain. Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx

MD COVID-19 - Cases per 100K population, by jurisdiction

<b>Note:</b> Starting April 27, 2023 updates change from daily to weekly. <b>Summary</b> The rate of confirmed COVID-19 cases among Marylanders per 100,000 people in each Maryland jurisdiction. <b>Description</b> The MD COVID-19 cases per 100K population, by jurisdiction layer is the rate of confirmed daily COVID-19 cases among Marylanders per 100,000 people in each Maryland jurisdiction. This rate is a 7-day average, calculated using the CasesByCounty layer and the 2019 estimated county populations (Maryland Department of Planning). Any negative value may be attributed to changes in reporting by jurisdiction. <b>Terms of Use</b> The Spatial Data, and the information therein, (collectively the "Data") is provided "as is" without warranty of any kind, either expressed, implied, or statutory. The user assumes the entire risk as to quality and performance of the Data. No guarantee of accuracy is granted, nor is any responsibility for reliance thereon assumed. In no event shall the State of Maryland be liable for direct, indirect, incidental, consequential or special damages of any kind. The State of Maryland does not accept liability for any damages or misrepresentation caused by inaccuracies in the Data or as a result to changes to the Data, nor is there responsibility assumed to maintain the Data in any manner or form. The Data can be freely distributed as long as the metadata entry is not modified or deleted. Any data derived from the Data must acknowledge the State of Maryland in the metadata.

MUNICIPAL_BOUNDARY

Delinquency Dispositions CY 2014 - Current By County as Reported by the Juvenile Court Judges' Commission

This dataset represents the total number of delinquency dispositions processed by Pennsylvania juvenile courts in 2018. A disposition is defined as an allegation of delinquency disposed of by the juvenile probation department and/or the court. This dataset is contained within the Juvenile Court Judges' Commission’s Calendar Year (CY) 2018 Juvenile Court Annual Report; this report provides an overview of Pennsylvania juvenile court statistics, during 2018, to measure and quantify work across the state by juvenile justice professionals. In Pennsylvania, juvenile court jurisdiction extends over individuals who have been alleged to have committed a delinquent act, as defined by 42. Pa. C. S. § 6301 et seq., on or after their tenth birthday and prior to reaching eighteen years of age. Juvenile court supervision can extend until the individual is twenty-one years of age if the individual is currently under supervision. Age for purposes of this section was calculated from the juvenile’s date of birth to the date of the offense in the written allegation. Any one youth may be involved in a number of dispositions within a calendar year containing multiple allegations. There were 22,023 delinquency dispositions in Pennsylvania during 2018. This represents a 1.3% decrease from 2017 and a 13.4% decrease since 2014. Allegheny County reported a decrease of 17.0% from 2017 to 2018, and Philadelphia County reported a 5.9% decrease for this time period. One-third of the total dispositions occurred in the four jurisdictions reporting more than 1,000 dispositions; these jurisdictions include Philadelphia, Allegheny, York, and Delaware.

Risky Prescribing Measures Quarter 3 2016 - Current Quarterly County & Statewide Health

View quarterly trends in Risky Prescribing Measures, including: o Number/Rate of Individuals Seeing 5+ Prescribers and 5+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence. o Number/Rate of Individuals Seeing 4+ Prescribers and 4+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence. o Number/Rate of Individuals Seeing 3+ Prescribers and 3+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence. o Number/Rate of Individuals with an Average Daily MME >50, >90 or >120: Average Daily MME is calculated as the sum of the total MME on each day in a time period based on all prescriptions an individual has filled divided by the number of days in the prescription(s). Measures include the number and rate of individuals prescribed greater than 50 MME per day, greater than 90 MME per day, or greater than 120 MME per day and is based on the patient’s county of residence. o Number/Rate of Individuals with Overlapping Opioid/Benzodiazepine Prescriptions: Number of individuals receiving overlapping opioid and benzodiazepine prescriptions during a given quarter. This measure is based on the patients’ county of residence. o Number/Rate of Individuals with > 30 Days of Overlapping Opioid/Benzodiazepine Prescriptions: Number and rate of individuals receiving overlapping opioid and benzodiazepine prescriptions for 30 days or more during a given quarter using state/county populations as denominators. This measure is based on the patients’ county of residence. Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx

MD COVID-19 - Total Population Tested by County

<b>Summary</b> This layer is deprecated (Last updated 3/14/2022). The total number of residents who have been administered at least one COVID-19 test in each Maryland jurisdiction. <b>Description</b> Data represent the number of Maryland residents, both in number and by percent of the population, who have been tested for COVID-19 at least once each Maryland jurisdiction. <b>Terms of Use</b> The Spatial Data, and the information therein, (collectively the "Data") is provided "as is" without warranty of any kind, either expressed, implied, or statutory. The user assumes the entire risk as to quality and performance of the Data. No guarantee of accuracy is granted, nor is any responsibility for reliance thereon assumed. In no event shall the State of Maryland be liable for direct, indirect, incidental, consequential or special damages of any kind. The State of Maryland does not accept liability for any damages or misrepresentation caused by inaccuracies in the Data or as a result to changes to the Data, nor is there responsibility assumed to maintain the Data in any manner or form. The Data can be freely distributed as long as the metadata entry is not modified or deleted. Any data derived from the Data must acknowledge the State of Maryland in the metadata.

Individuals under Medical Assistance (Newly Eligible) Diagnosed with Opioid Use Disorder CY 2015-Current Annual County Human Services

This dataset contains the total counts of PA Department of Human Services (DHS) Medical Assistance (MA) individuals diagnosed with Opioid Use Disorder (OUD) or OUD Poisoning. Also included are individuals receiving MAT (Medication assisted treatment - the use of medications in combination with counseling and behavioral therapies for the treatment of substance use disorders.) NOT diagnosed in the same period. Limited to the Newly Eligible (Under the Medical Assistance Expansion Program. Find more information here: http://www.dhs.pa.gov/cs/groups/webcontent/documents/document/c_257436.pdf) segment of DHS population. Internally defined as DHS Category of Assistance = MG (Modified Adjusted Gross Income - MAGI) MG and Program Status = 91 (Newly Eligible). Counts are reported by Pennsylvania case county and covers calendar years 2015 -2018.